CALL/ILLUMINA/250/0.1/20.09.24 Stock

Warrant

DE000GP9XJD2

Market Closed - Bid/Ask 02:25:53 2024-05-23 pm EDT After market 03:58:27 pm
0.077 EUR +16.67% Intraday chart for CALL/ILLUMINA/250/0.1/20.09.24 0.15 +94.81%
Current month+6.45%
1 month-1.49%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 0.077 +16.67%
24-05-22 0.066 +94.12%
24-05-21 0.034 -8.11%
24-05-20 0.037 -33.93%
24-05-17 0.056 -34.88%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 02:25 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ILLUMINA, INC.
Issuer Goldman Sachs
WKN GP9XJD
ISINDE000GP9XJD2
Date issued 2023-07-21
Strike 250 $
Maturity 2024-09-20 (120 Days)
Parity 10 : 1
Emission price 1.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.98
Lowest since issue 0.026
Spread 0.15
Spread %65.22%

Company Profile

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (15.9%). Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).
Sector
-
More about the company

Ratings for Illumina, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Illumina, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
107.4 USD
Average target price
155.5 USD
Spread / Average Target
+44.81%
Consensus